General Characteristics.
| Age: | 66 years |
| Gender: | Male |
| Disease Origin: | Clival |
| Disease Status: | Primary |
| Prior Radiation: | Yes |
| Prior Systemic Therapy: | Yes |
| Source: | Dr. Mark Prince and John Henry Owen University of Michigan |
Molecular Features
| Cell Morphology: | Physaliferous |
| TBXT Expression: | Positive; 6x that of U-CH2 |
| TBXT Localization: | Nuclear |
| CD24 Expression: | Positive; 3x that of U-CH2 |
| HLA Type: | A2, A3 (ambiguous allele combination) |
| Sequence Data: | WGS, exome and transcriptome data available: raw sequencing data in Cavatica (Chordoma Foundation Dataset) and summary data in PedcBioportal. Contact researchteam@chordoma.org with any questions. |
| SMARCB1 Status: | No expression |
| Validation Results: | Validation Report |
Growth Conditions
| Growth Medium: | IMDM: RPMI-1640 (4:1) +10% FBS |
| Freeze Medium: | 70% complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO |
| Culture Conditions: | Temperature: 37°C Atmosphere: air, 95%; carbon dioxide (CO2), 5% |
| Subculturing Instructions: | Cell Culture Procedures |
Publications
Characterized By:
|